LEADER 00787nam0-22002891i-450- 001 990000848350403321 005 20001010 035 $a000084835 035 $aFED01000084835 035 $a(Aleph)000084835FED01 035 $a000084835 100 $a20001010d--------km-y0itay50------ba 101 0 $aita 105 $ay-------001yy 200 1 $aIntroduction to topological group 210 $aCambridge$cCambridge University Press$d1974 215 $aIV,109 p.$d23 cm 225 1 $aLecture Note series$v1 5 700 1$aHiggins,$bPhilip J.$047754 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990000848350403321 952 $a02 14 D27$b1904$fFINBN 959 $aFINBN 996 $aIntroduction to topological group$9348566 997 $aUNINA DB $aING01 LEADER 01806nam0 22003253i 450 001 SUN0114989 005 20181017112137.939 010 $a978-92-87183-29-3$d0.00 100 $a20180219d2017 |0engc50 ba 101 $aeng 102 $aFR 105 $a|||| ||||| 200 1 $a*European Pharmacopoeia$eSupplement 9.5$fpublished in accordance with the Convention on the elaboration of a European Pharmacopoeia (European treaty series No$h50) 205 $a9. ed 210 $aStrasbourg$cCouncil of Europe$d2017 215 $aXLV-XLVI, 5533-5816 p.$d30 cm 422 1$1001SUN0114972$12001 $a*European pharmacopoeia$fpublished in accordance with the Convention on the elaboration of a European Pharmacopoeia (European treaty series No$h50)$v9.5$1205 $a9. ed$1210 $aStrasbourg$cCouncil of Europe$d2016$1215 $avolumi$d30 cm. 620 $dStrasburgo$3SUNL001124 676 $a615.11$cFarmacopee$v22 712 02$aCouncil of Europe$3SUNV033189 712 02$aEDQM$3SUNV088981 712 $aCouncil of Europe$3SUNV001822$4650 791 02$aEuropean Directorate for the Quality of Medicines & HealtCare$zEDQM$3SUNV088982 801 $aIT$bSOL$c20190408$gRICA 856 4 $u/sebina/repository/catalogazione/documenti/Indice European Pharmacopoeia Supplement 9.5.pdf 912 $aSUN0114989 950 $aUFFICIO DI BIBLIOTECA DEL DIPARTIMENTO DI SCIENZE E TECNOLOGIE AMBIENTALI BIOLOGICHE E FARMACEUTICHE$d17CONS Ua133 $e17BIB1911 20181109 $sBuono 950 $aUFFICIO DI BIBLIOTECA DEL DIPARTIMENTO DI SCIENZE E TECNOLOGIE AMBIENTALI BIOLOGICHE E FARMACEUTICHE$d17PREST Ua125 $e17BIB1910 20180619 $sBuono 996 $aEuropean pharmacopoeia$9724240 997 $aUNICAMPANIA